Despite its broad application, amoxicillin’s effectiveness against staphylococci is nuanced. While it can target certain strains, its activity is limited against those producing beta-lactamase, an …

Amox-clav has activity versus MSSA, but amoxicillin alone only has activity against penicillin-sensitive Staphylococcus aureus Requires dosage adjustment for renal insufficiency

Amoxicillin can cover penicillin-susceptible Staph aureus (PSSA) Amox/clav has activity versus Gram negative anaerobes associated with human and animal bite wounds, making it a go-to …

* No clinical data are available, but listed antibiotics appear to be active in vitro. MRSA = methicillin-resistant Staphylococcus aureus. Brought to you by Merck & Co, Inc., Rahway, NJ, …

The experimental and clinical values of amoxycillin/clavulanate in severe Staphylococcus aureus infections are reviewed. Experimentally, amoxycillin/clavulanate was highly effective in the …

Staph can progress into a MRSA infection, which will not respond to common antibiotics. Antibiotics for Staph can be taken orally, topically or intravenously (IV), depending on the type …

Cephalosporins have in-vitro activity for SPACE organisms but induce production of beta-lactamases Tigecycline has no activity against Pseudomonas aeruginosa, but for …

• Gram negative ‘coliforms’ (eg E. coli, Klebsiella, Enterobacter, Proteus) & Pseudomonas aeruginosa are usually sensitive to gentamicin. Amoxicillin only covers 50% of E. coli: when …

Drugs such as amoxicillin and ampicillin are beta-lactamase susceptible and should not be relied upon to treat lower extremity Staph infections. Patients will often begin self-treatment with …

Staphylococcus aureus was isolated from all patients and β-hemolytic streptococcus from 14 (29%). All staphylococci were sensitive to Augmentin but resistant to amoxicillin. Forty-nine …